GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indoco Remedies Ltd (BOM:532612) » Definitions » Net Interest Income

Indoco Remedies (BOM:532612) Net Interest Income : ₹-573 Mil (TTM As of Dec. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Indoco Remedies Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Indoco Remedies's net interest income for the three months ended in Dec. 2024 was ₹-161 Mil. Its net interest income for the trailing twelve months (TTM) ended in Dec. 2024 was ₹-573 Mil.

Indoco Remedies Net Interest Income Historical Data

The historical data trend for Indoco Remedies's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indoco Remedies Net Interest Income Chart

Indoco Remedies Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Interest Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -223.87 -213.11 -169.58 -246.92 -350.51

Indoco Remedies Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -100.70 -90.81 -143.10 -178.30 -161.10

Indoco Remedies Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-573 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indoco Remedies Net Interest Income Related Terms

Thank you for viewing the detailed overview of Indoco Remedies's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Indoco Remedies Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indoco Remedies Ltd (BOM:532612) » Definitions » Net Interest Income
Comparable Companies
BOM:541540 BOM:543329 BOM:539872 BOM:500672 NSE:BETA BOM:590006 BOM:530239 BOM:524164 BOM:500288 BOM:524470 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
INDOCO:India
Address
166 CST Road, Indoco House, Kalina, Santacruz (East), Mumbai, MH, IND, 400 098
Website
https://www.indoco.com
Indoco Remedies Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The company manufactures products for different therapeutic sectors including Gastroenterology, Dentistry & Stomatology, Respiratory, Diabetology, Women's Health, Nutritional products, Cardiology, Metabolic Disorders, and Primary Care medicines. The only operating segment of the company is Pharmaceutical Products. Geographically, it generates the majority of the revenue from India.

Indoco Remedies Headlines

No Headlines